-
Recent progress of dendritic cell-derived exosomes in tumor immunotherap
Author: Wang, Baiyan; Hu, Yirui; Zhou, Yujia; Han, Qianqian; Huang, Yu; Dong, Yuanhang; Zhang, Yike; Guo, Zixuan; Zhang, Xuan; Feng, Shuying
Journal: INVESTIGATIONAL NEW DRUGS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10637-026-01604-4
-
Spatial blueprint of colorectal cancer identifies Hypoxic CAF program that orchestrates Go-or-Grow decisions and predicts outcome
Author: Chen, Mingkai; Yang, Juan; Wang, Jin; Du, Guangrun; Zhang, Lida
Journal: INVESTIGATIONAL NEW DRUGS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10637-026-01611-5
-
Crocetin suppresses colorectal cancer progression by targeting TGM2 and inhibiting the JAK2/STAT3 pathwa
Author: Chen, Shuo; Su, Weijun; Wang, Kai; Xu, Mingyue; Su, Binjie
Journal: INVESTIGATIONAL NEW DRUGS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10637-026-01608-0
-
Clinical pharmacokinetic characteristics and the food effect of radotini
Author: Lee, Yerin; Kim, Jiwon; Kang, Minseo; Han, Jiwon; Kim, Na Yun; Shin, Jae Soo; Park, Min Soo; Jiang, Qian; Lee, Jangik I
Journal: INVESTIGATIONAL NEW DRUGS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10637-026-01610-6
-
Clinical features, treatment and outcomes of pembrolizumab induced autoimmune hemolytic anemi
Author: Liu, Jieqiong; Sun, Wei; Wang, Chunjiang
Journal: INVESTIGATIONAL NEW DRUGS. 2026; Vol. , Issue , pp. -. DOI: 10.1007/s10637-026-01596-1
-
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activit
Author: Azad, Arun A.; Gurney, Howard; Underhill, Craig; Horvath, Lisa; Voskoboynik, Mark; Li, Xinghai; King, Ivan; Shao, Lisa; Dai, Yiyun; Perabo, Frank
Journal: INVESTIGATIONAL NEW DRUGS. 2025; Vol. 43, Issue 2, pp. 435-445. DOI: 10.1007/s10637-025-01533-8
-
Orelabrutinib combined with rituximab and high-dose methotrexate as induction therapy in newly diagnosed primary central nervous system lymphom
Author: Xiao, Xi-Bin; Weng, Yi-Qin; Jiang, Hua-Wei; Li, Xian; Xie, Jing; Bao, Chang-Qian; Qian, Wen-Bin
Journal: INVESTIGATIONAL NEW DRUGS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s10637-025-01548-1
-
Efficacy and safety of orelabrutinib combined with rituximab and high dose methotrexate in primary or secondary central nervous system diffuse large B-cell lymphoma: a retrospective analysi
Author: Zhou, Jiahao; Xing, Lingxiao; Miao, Yi; Qin, Shuchao; Zhang, Run; Tang, Hanning; Xu, Wei; Xia, Yi; Zhu, Huayuan; Li, Jianyong
Journal: INVESTIGATIONAL NEW DRUGS. 2025; Vol. , Issue , pp. -. DOI: 10.1007/s10637-025-01542-7
